Guggulsterone suppresses the activation of transcription factor IRF3 induced by TLR3 or TLR4 agonists

International Immunopharmacology

Volumn 9, Issue 1, 2009, Pages 108-112

  Youn, Hyung Sun ^a   Ahn, Sang Il ^a   Lee, Boo Yong ^b  

^a Soonchunhyang University   (South Korea)

^b CHA University   (South Korea)

Author keywords

Guggulsterone; IRF3; LPS; MyD88; Poly I:C ; Toll like receptors; TRIF

Indexed keywords

GUGGULSTERONE; I KAPPA B KINASE; INTERFERON REGULATORY FACTOR 3; LIPOPOLYSACCHARIDE; MYELOID DIFFERENTIATION FACTOR 88; POLYINOSINIC POLYCYTIDYLIC ACID; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME INHIBITION; GENE ACTIVATION; GENE EXPRESSION; GENE OVEREXPRESSION; INFLAMMATION; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; ANIMALS; BIOTRANSFORMATION; BLOTTING, WESTERN; HUMANS; INDICATORS AND REAGENTS; INTERFERON REGULATORY FACTOR-3; LUCIFERASES; MICE; NF-KAPPA B; PHOSPHORYLATION; PLASMIDS; PREGNENEDIONES; TOLL-LIKE RECEPTOR 3; TOLL-LIKE RECEPTOR 4; TRANSFECTION;

EID: 58149467005     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2008.10.012     Document Type: Article

References (40)

1. Surh Y.J. Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 3 (2003) 768-780
2. Urizar N.L., and Moore D.D. GUGULIPID: a natural cholesterol-lowering agent. Annu Rev Nutr 23 (2003) 303-313
3. Sinal C.J., and Gonzalez F.J. Guggulsterone: an old approach to a new problem. Trends Endocrinol Metab 13 (2002) 275-276
4. Gujral M.L., Sareen K., Tangri K.K., Amma M.K., and Roy A.K. Antiarthritic and anti-inflammatory activity of gum guggul (Balsamodendron mukul Hook). Indian J Physiol Pharmacol 4 (1960) 267-273
5. Sharma J.N. Comparison of the anti-inflammatory activity of Commiphora mukul (an indigenous drug) with those of phenylbutazone and ibuprofen in experimental arthritis induced by mycobacterial adjuvant. Arzneimittelforschung 27 (1977) 1455-1457
6. Arora R.B., Taneja V., Sharma R.C., and Gupta S.K. Anti-inflammatory studies on a crystalline steroid isolated from Commiphora mukul. Indian J Med Res 60 (1972) 929-931
7. Shishodia S., and Aggarwal B.B. Guggulsterone inhibits NF-kappaB and IkappaBalpha kinase activation, suppresses expression of anti-apoptotic gene products, and enhances apoptosis. J Biol Chem 279 (2004) 47148-47158
8. Ichikawa H., and Aggarwal B.B. Guggulsterone inhibits osteoclastogenesis induced by receptor activator of nuclear factor-kappaB ligand and by tumor cells by suppressing nuclear factor-kappaB activation. Clin Cancer Res 12 (2006) 662-668
9. Cheon J.H., Kim J.S., Kim J.M., Kim N., Jung H.C., and Song I.S. Plant sterol guggulsterone inhibits nuclear factor-kappaB signaling in intestinal epithelial cells by blocking IkappaB kinase and ameliorates acute murine colitis. Inflamm Bowel Dis 12 (2006) 1152-1161
10. Medzhitov R., Preston-Hurlburt P., and Janeway Jr. C.A. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388 (1997) 394-397
11. Takeda K., and Akira S. Toll-like receptors in innate immunity. Int Immunol 17 (2005) 1-14
12. Doyle S.L., and O'Neill L.A. Toll-like receptors: from the discovery of NFkappaB to new insights into transcriptional regulations in innate immunity. Biochem Pharmacol 72 (2006) 1102-1113
13. Akira S., and Takeda K. Toll-like receptor signalling. Nat Rev Immunol 4 (2004) 499-511
14. Rhee S.H., and Hwang D. Murine TOLL-like receptor 4 confers lipopolysaccharide responsiveness as determined by activation of NF kappa B and expression of the inducible cyclooxygenase. J Biol Chem 275 (2000) 34035-34040
15. Lin R., Heylbroeck C., Pitha P.M., and Hiscott J. Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation. Mol Cell Biol 18 (1998) 2986-2996
16. Navarro L., and David M. p38-dependent activation of interferon regulatory factor 3 by lipopolysaccharide. J Biol Chem 274 (1999) 35535-35538
17. Fitzgerald K.A., McWhirter S.M., Faia K.L., Rowe D.C., Latz E., Golenbock D.T., et al. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol 4 (2003) 491-496
18. Kawai T., Takeuchi O., Fujita T., Inoue J., Muhlradt P.F., Sato S., et al. Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J Immunol 167 (2001) 5887-5894
19. Gao J.J., Filla M.B., Fultz M.J., Vogel S.N., Russell S.W., and Murphy W.J. Autocrine/paracrine IFN-alphabeta mediates the lipopolysaccharide-induced activation of transcription factor Stat1alpha in mouse macrophages: pivotal role of Stat1alpha in induction of the inducible nitric oxide synthase gene. J Immunol 161 (1998) 4803-4810
20. Youn H.S., Saitoh S.I., Miyake K., and Hwang D.H. Inhibition of homodimerization of Toll-like receptor 4 by curcumin. Biochem Pharmacol 72 (2006) 62-69
21. Youn H.S., Lee J.Y., Saitoh S.I., Miyake K., Kang K.W., Choi Y.J., et al. Suppression of MyD88- and TRIF-dependent signaling pathways of Toll-like receptor by (-)-epigallocatechin-3-gallate, a polyphenol component of green tea. Biochem Pharmacol 72 (2006) 850-859
22. Youn H.S., Lee J.Y., Fitzgerald K.A., Young H.A., Akira S., and Hwang D.H. Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: molecular targets are TBK1 and RIP1 in TRIF complex. J Immunol 175 (2005) 3339-3346
23. Kawai T., and Akira S. Signaling to NF-kappaB by Toll-like receptors. Trends Mol Med 13 (2007) 460-469
24. Zandi E., Rothwarf D.M., Delhase M., Hayakawa M., and Karin M. The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation. Cell 91 (1997) 243-252
25. Yamaoka S., Courtois G., Bessia C., Whiteside S.T., Weil R., Agou F., et al. Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation. Cell 93 (1998) 1231-1240
26. Lin R., Heylbroeck C., Genin P., Pitha P.M., and Hiscott J. Essential role of interferon regulatory factor 3 in direct activation of RANTES chemokine transcription. Mol Cell Biol 19 (1999) 959-966
27. Schafer S.L., Lin R., Moore P.A., Hiscott J., and Pitha P.M. Regulation of type I interferon gene expression by interferon regulatory factor-3. J Biol Chem 273 (1998) 2714-2720
28. Stetson D.B., and Medzhitov R. Type I interferons in host defense. Immunity 25 (2006) 373-381
29. Wietek C., and O'Neill L.A. Diversity and regulation in the NF-kappaB system. Trends Biochem Sci 32 (2007) 311-319
30. Honda K., and Taniguchi T. IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol 6 (2006) 644-658
31. Peters R.T., and Maniatis T. A new family of IKK-related kinases may function as I kappa B kinase kinases. Biochim Biophys Acta 1471 (2001) M57-62
32. Shimada T., Kawai T., Takeda K., Matsumoto M., Inoue J., Tatsumi Y., et al. IKK-i, a novel lipopolysaccharide-inducible kinase that is related to IkappaB kinases. Int Immunol 11 (1999) 1357-1362
33. Aupperle K.R., Yamanishi Y., Bennett B.L., Mercurio F., Boyle D.L., and Firestein G.S. Expression and regulation of inducible IkappaB kinase (IKK-i) in human fibroblast-like synoviocytes. Cell Immunol 214 (2001) 54-59
34. Hemmi H., Takeuchi O., Sato S., Yamamoto M., Kaisho T., Sanjo H., et al. The roles of two IkappaB kinase-related kinases in lipopolysaccharide and double stranded RNA signaling and viral infection. J Exp Med 199 (2004) 1641-1650
35. McWhirter S.M., Fitzgerald K.A., Rosains J., Rowe D.C., Golenbock D.T., and Maniatis T. IFN-regulatory factor 3-dependent gene expression is defective in Tbk1-deficient mouse embryonic fibroblasts. Proc Natl Acad Sci U S A 101 (2004) 233-238
36. Perry A.K., Chow E.K., Goodnough J.B., Yeh W.C., and Cheng G. Differential requirement for TANK-binding kinase-1 in type I interferon responses to toll-like receptor activation and viral infection. J Exp Med 199 (2004) 1651-1658
37. Bjorkbacka H., Fitzgerald K.A., Huet F., Li X., Gregory J.A., Lee M.A., et al. The induction of macrophage gene expression by LPS predominantly utilizes Myd88-independent signaling cascades. Physiol Genomics 19 (2004) 319-330
38. Urizar N.L., Liverman A.B., Dodds D.T., Silva F.V., Ordentlich P., Yan Y., et al. A natural product that lowers cholesterol as an antagonist ligand for FXR. Science 296 (2002) 1703-1706
39. Cui J., Huang L., Zhao A., Lew J.L., Yu J., Sahoo S., et al. Guggulsterone is a farnesoid X receptor antagonist in coactivator association assays but acts to enhance transcription of bile salt export pump. J Biol Chem 278 (2003) 10214-10220
40. Ichikawa H., and Aggarwal B.B. Guggulsterone inhibits osteoclastogenesis induced by receptor activator of nuclear factor-kappaB ligand and by tumor cells by suppressing nuclear factor-kappaB activation. Clin Cancer Res 12 (2006) 662-668